• Advertise
  • Feedback
  • About Us
  • Contact Us
Saturday, July 2, 2022
Hello Guwahati
  • Home
  • News
    • Guwahati News
    • State
    • National
    • International
    • Science & Technology
    • Sports
    • New Delhi
  • Inside Guwahati
  • Leisure
    • Entertainment
    • Food
    • Health
    • Lifestyle
  • New in City
  • Colourful Northeast
No Result
View All Result
  • Home
  • News
    • Guwahati News
    • State
    • National
    • International
    • Science & Technology
    • Sports
    • New Delhi
  • Inside Guwahati
  • Leisure
    • Entertainment
    • Food
    • Health
    • Lifestyle
  • New in City
  • Colourful Northeast
No Result
View All Result
Hello Guwahati
No Result
View All Result
Home Leisure Health

India & UK to conduct clinical trials of ‘Ashwagandha’ for promoting recovery from COVID-19

Hello Guwahati by Hello Guwahati
01/08/2021 10:42 pm
in Health
0 0
0
India & UK to conduct clinical trials of ‘Ashwagandha’ for promoting recovery from COVID-19
0
SHARES
28
VIEWS
ShareShareShareShare
ADVERTISEMENT

Guwahati News Desk: The Ministry of Ayush has collaborated with the UK’s London School of Hygiene and Tropical Medicine (LSHTM) to conduct a study on ‘Ashwagandha’ for promoting recovery from COVID-19.

As per the Ministry release, the All India Institute of Ayurveda (AIIA), an autonomous body under the Ministry of Ayush and the LSHTM recently signed a ‘Memorandum of Understanding’ to conduct clinical trials of ‘Ashwagandha’ on 2,000 people in three U.K. cities, including Leicester, Birmingham and London (Southall and Wembley).

The release added that the successful completion of the trial could be a major breakthrough and it might give scientific validity to India’s traditional medicinal system.

Regarding the ‘Ashwagandha’, it is also commonly known as ‘Indian winter cherry’, is a traditional Indian herb that boosts energy, reduces stress and makes the immune system stronger. It is easily accessible, is an over-the-counter nutritional supplement in the UK and has a proven safety profile.

Infact, the positive effects of ‘Ashwagandha’ have been observed in Long COVID, which is a multi-system disease with no evidence of its effective treatment or management.

The Ministry stated, “While there have been several studies on ‘Ashwagandha’ to understand its benefits in various ailments, this is the first time the Ministry of Ayush has collaborated with a foreign institution to investigate its efficacy on COVID-19 patients.’’

According to AIIA director, Tanuja Manoj Nesari, who is also a co-investigator in the project along with Rajgopalan, the coordinator of International Projects, the participants have been randomly selected. Among the participants, Sanjay Kinra of the LSHTM is the principal investigator of the study.

Dr. Nesari stated, “For three months, one group of 1,000 participants will be administered ‘Ashwagandha’ (AG) tablets, while the second group of 1,000 participants will be assigned a placebo, which is indistinguishable from AG in looks and taste. Both patients and the doctors will be unaware of the group’s treatment in a double-blind trial.”

The participants will have to take the 500mg tablets twice a day. A monthly follow-up of self-reported quality of life, impairment to activities of daily living, mental and physical health symptoms, supplement use and adverse events will be carried out.

Meanwhile, a number of recent trials of AG in humans in India have demonstrated its efficacy in reducing anxiety and stress, improving muscle strength and reducing symptoms of fatigue in patients treated for chronic conditions. It has also been indicated for treating non-restorative sleep, a hallmark of chronic fatigue, for which the trials are currently ongoing. Combined with substantial literature on its pharmacological and immuno modulatory effects in vitro and in animals, the study suggests ‘Ashwagandha’ as a potential therapeutic candidate for alleviating the long-term symptoms of COVID-19.
The Ministry further added – “After the trial’s success, ‘Ashwagandha’ will be a proven medicinal treatment to prevent infection and be recognized by the scientific community worldwide,”

Tags: Covid NewsHealth newsIndiaUnited Kingdom
ADVERTISEMENT
Previous Post

Turkey engulfed in raging flames

Next Post

‘Fair, reasonable & mutually acceptable solution’ to border disputes: Weidong

Hello Guwahati

Hello Guwahati

Next Post
‘Fair, reasonable & mutually acceptable solution’ to border disputes: Weidong

'Fair, reasonable & mutually acceptable solution' to border disputes: Weidong

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

ADVERTISEMENT

Recent News

Global CEO of INIFD interacted with Design students in INIFD Guwahati

Global CEO of INIFD interacted with Design students in INIFD Guwahati

July 1, 2022
Assam CM gibes ‘we will get GST, revenue’ as rebel Shiv Sena MLAs reach Guwahati.

Assam CM gibes ‘we will get GST, revenue’ as rebel Shiv Sena MLAs reach Guwahati.

June 22, 2022
6th edition of LinkedIn Local for Start-ups and entrepreneurship held in Guwahati

6th edition of LinkedIn Local for Start-ups and entrepreneurship held in Guwahati

June 20, 2022
Unidentified body recovered in Guwahati

Dead body recovered at Basistha area: Guwahati

June 19, 2022

Stay Connected test

  • 10.3k Fans
Hello Guwahati

The biggest and the busiest hub of Northeast India 24x7 News Media House.

Copyright for all content remains solely with Hello Guwahati. The news stories or content including images and videos can be re-published and re-telecast by other parties only with prior approval of Hello Guwahati with the condition that other parties must include the link to the original post by Hello Guwahati in their posts.

Follow Us

Contact us :

Hello Guwahati
(A unit of Pinnacle Media Agency)

327, New Airport Road, Dharapur, Garal, Near Uttarayan Shreejoni, Guwahati 781017, Assam, India
Ph: +91 98545 55024
Mail: onhelloguwahati@gmail.com

  • Advertise
  • Feedback
  • About Us
  • Contact Us

© 2020 HelloGuwahati.in - Powered By Sigma Design India

No Result
View All Result
  • Home
  • News
    • Guwahati News
    • State
    • National
    • International
    • Science & Technology
    • Sports
    • New Delhi
  • Inside Guwahati
  • Leisure
    • Entertainment
    • Food
    • Health
    • Lifestyle
  • New in City
  • Colourful Northeast

© 2020 HelloGuwahati.in - Powered By Sigma Design India

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In